Anzeige
Mehr »
Lynx Broker
Login
Mittwoch, 16.10.2019 Börsentäglich über 12.000 News von 613 internationalen Medien
Mega-Chance im Tech-Sektor +++ Konkurrenz tief beeindruckt +++ Aktie noch günstig
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0Q40S ISIN: AU000000AVH4 Ticker-Symbol: GCR 
Tradegate
14.10.19
17:27 Uhr
0,368 Euro
0,000
0,00 %
1-Jahres-Chart
AVITA MEDICAL LTD Chart 1 Jahr
5-Tage-Chart
AVITA MEDICAL LTD 5-Tage-Chart
RealtimeGeldBriefZeit
0,352
0,378
08:46
0,348
0,380
08:16

Aktuelle News zur AVITA MEDICAL Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiAVITA MEDICAL LTD: Filing of Foreign Documents5
FrAvita Medical, Ltd. - 6-K, Report of foreign issuer4
DoAVITA MEDICAL LTD: Annual Report to Shareholders14
Börsennews zur AVITA MEDICAL Aktie und weiteren Hot Stocks erhalten
01.10.AVITA MEDICAL LTD: Appendix 3B11
30.09.AVITA MEDICAL LTD: Ceasing to be a substantial holder from MUFG6
30.09.Avita Medical, Ltd. - 6-K, Report of foreign issuer3
30.09.AVITA Medical Announces Listing on Nasdaq156Trading of American Depository Shares to begin under the ticker symbol "RCEL" on October 1st AVITA Medical (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned...
► Artikel lesen
30.09.AVITA MEDICAL LTD: Becoming a substantial holder from MUFG10
30.09.AVITA MEDICAL LTD: AVITA Medical Announces Listing on Nasdaq6
29.09.AVITA MEDICAL LTD: Appendix 4G and Corporate Governance Statement1
29.09.AVITA MEDICAL LTD: Full Year Statutory Accounts-
29.09.AVITA MEDICAL LTD: Ceasing to be a substantial holder from MS2
27.09.AVITA MEDICAL LTD: Becoming a substantial holder from MS12
24.09.AVITA MEDICAL LTD: Change in substantial holding8
19.09.AVITA MEDICAL LTD: Data Investigates RECELL to Treat Dermatological Conditions11
17.09.FDA OKS Avita Medical trial for Recell in soft tissue reconstruction8
17.09.AVITA Medical Receives U.S. FDA Investigational Device Exemption Approval of Pivotal Study Evaluating RECELL System for Soft Tissue Reconstruction349First RECELL System clinical trial in the U.S. focused on acute soft tissue injuries, defects, and reconstruction; study expected to commence within next 6 months AVITA Medical (ASX: AVH, OTCQX:...
► Artikel lesen
17.09.AVITA MEDICAL LTD: Pivotal Soft Tissue Trial Receives US FDA IDE Approval5
16.09.AVITA MEDICAL LTD: Change in substantial holding8
11.09.AVITA MEDICAL LTD: Change of Joint Company Secretary6
Seite:  Weiter >>
76 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,3